![](http://pinterest.com/pin/create/button/?url=http://trecnews4u.blogspot.com/2014/05/seleksi-hpv-utama-menawarkan-opsi-baru.html&media=https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjXEqQmzzRIHJ6h1XlW_aB_BOpWQezPFhrLZJXNW0ffSCsuv9yTjZNaEOmKtajOiy8GRuKI0-NLoaPANO4JuSu7bLQaWXQXi6uhlguoaoaWIL63vrmdELvLFfhh4BxxPPtP1c3S3udmrwol/s72-c/hpv--medicalnewstoday+dot+com.jpg&description=....SILAHKAN MENGGUNAKAN " MESIN TRANSLATE "..GOOGLE TRANSLATEÂ DISAMPING KANAN INI............. PLEASE USE ........ "...){kind=link}
DISAMPING KANAN INI.............
PLEASE USE ........ "TRANSLATE MACHINE" .. GOOGLE TRANSLATE BESIDE RIGHT THIS
..................
Primary
HPV screening offers important new option for cervical cancer detection,
prevention
Primary
HPV screening offers important new option for cervical cancer detection,
prevention
Date:
April 24,
2014
Source:
Society of Gynecologic Oncology
Summary:
New options for detecting and preventing cervical
cancer have been welcomed recently into the scientific community, including the
primary human papillomavirus (HPV) testing recently approved by the FDA.
Primary HPV testing does not replace the Pap test, and it is extremely unlikely
that doctors will stop using the Pap any time soon. However, FDA approval of
primary HPV testing means the HPV test can be used first when screening a woman
for cervical cancer.
.........................
The FDA approval of primary human papillomavirus (HPV) testing will provide
doctors one more tool to use in cervical cancer screening, a health routine
responsible for saving countless lives. As the largest organization of doctors
specializing in the treatment of women's cancers, including cervical cancer,
the Society of Gynecologic Oncology (SGO) welcomes new options for detecting
and preventing this terrible disease. We also are aware that the approval has
raised a number of questions about how HPV testing will be used and whether the
Pap test will continue to play a role in cervical cancer screening. Primary HPV testing does not replace the Pap test, and
it is extremely unlikely that doctors will stop using the Pap any time soon.
FDA approval of primary HPV testing means the HPV test can be used first when
screening a woman for cervical cancer. The two tests screen for cervical cancer
in different ways. The HPV test detects the presence of the HPV types
responsible for most cervical cancer, and can help identify women at high risk
for developing cervical cancer. The Pap test finds pre-cancer and cancer.
Having more options for using each of these tests gives doctors more
flexibility in choosing the best screening strategy for each individual
patient.
SGO and
other organizations are developing an interim guidance document to help health
care professionals determine how to best incorporate primary HPV testing into
cervical cancer screening. In the meantime, current guidelines for when to use
the HPV test remain in effect -- when Pap test results are inconclusive and in
women age 30 and older in combination with a Pap test.
Women should
discuss with their doctors the best cervical cancer screening option for them.
We also urge parents to have their daughters and sons vaccinated against the
HPV virus. The vaccine is safe and effective and perhaps the best tool yet in
preventing cervical cancer.
Story
Source:
The above
story is based on materials provided by Society of Gynecologic Oncology. Note: Materials
may be edited for content and length.
Cite This
Page:
Society of Gynecologic Oncology.
"Primary HPV screening offers important new option for cervical cancer
detection, prevention." ScienceDaily. ScienceDaily, 24 April 2014.
<www.sciencedaily.com/releases/2014/04/140424161535.htm>.
